SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-047124
Filing Date
2013-08-30
Accepted
2013-08-30 18:26:08
Documents
1
Period of Report
2013-08-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd389482.html 4  
1 PRIMARY DOCUMENT rrd389482.xml 4 12299
  Complete submission text file 0001181431-13-047124.txt   13986
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21900 BURBANK BOULEVARD, 3RD FLOOR WOODLAND HILLS CA 91367
Business Address
Bender James G. (Reporting) CIK: 0001550455 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 131073590